Marimed Inc. (MRMD) intrinsic value & 10-year financials
Marimed Inc. (MRMD) has a Graham intrinsic value of $1.33 per share. At $0.06 on Oct 17, 2026, the stock trades 95% below that value. Over the last 10 fiscal years revenue grew 52.6% a year to $159.8M, with an average return on invested capital of -3.7%.
- Graham intrinsic value
- $1.33
- Share price (Oct 17, 2026)
- $0.06
- Price vs Graham value
- 95% below
- Market cap
- $23.0M
- Revenue (FY2025)
- $159.8M
- Revenue growth (10-yr CAGR)
- 52.6%
- ROIC (10-yr avg)
- -3.7%
- Free cash flow (FY2025)
- $6.5M
MRMD 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $159.8M | -$14.5M | -$0.04 | $6.5M | -1.8% | -2.1% |
| FY2024 | $158.0M | -$12.2M | -$0.03 | -$5.2M | 1.8% | 2.8% |
| FY2023 | $148.6M | -$16.0M | -$0.04 | -$12.2M | 9.7% | 24.4% |
| FY2022 | $134.0M | $13.5M | $0.04 | -$4.8M | 15.2% | 44.7% |
| FY2021 | $121.5M | $7.2M | $0.02 | $18.0M | 22.1% | 46.4% |
| FY2020 | $50.9M | $2.1M | $0.01 | -$1.3M | 28.6% | 15.7% |
| FY2019 | $16.6M | -$81.2M | -$0.39 | -$33.8M | -251.0% | -69.3% |
| FY2018 | $11.9M | -$13.6M | — | -$11.8M | -45.2% | -18.7% |
| FY2017 | $6.1M | -$1.2M | — | -$19.7M | 19.9% | -22.8% |
| FY2016 | $3.6M | $321.2K | — | -$3.6M | 17.2% | -58.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
MARIMED INC. is a consistent compounder, expanding top-line revenue at 52.6% annually over the past decade.
MARIMED INC. has historically struggled to out-earn its cost of capital, averaging just -3.7% ROIC.
MARIMED INC. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, MARIMED INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $1.33 per share.